Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study

Thrombosis Journal

Table 2 Characteristics, management and clinical outcomes of the 10 bleeding events

No	Site of bleeding	Bleeding severity	Bleeding occurrence	Management	Length of stay (days)	90-day outcome
1	Hematuria	NMCR	Trauma	–	0	Alive
2	Gastrointestinal	Major	Spontaneous	RBC (3 units)^a	N/K	N/K
3	Gastrointestinal	Major	Spontaneous	RBC (2 units)^a	3	Alive
4	Gastrointestinal	Major	Spontaneous	RBC (3 units)^a	1	Alive
5	Intracranial	Major	Trauma	PCC (2500 IU)	43	Alive
6	Gastrointestinal	NMCR	Post-intervention	–	0	Alive
7	Epistaxis	NMCR	Spontaneous	–	2	Alive
8	Intracranial	Major	Trauma	–	1	Alive
9	Hematuria	NMCR	Spontaneous	–	0	Alive
10	Hematoma	NMCR	Trauma	–	0	N/K

N/K not known, NMCR non-major clinically relevant, PCC prothrombin complex concentrates, RBC red blood cells. ^aTransfusion before blood sampling

ISSN: 1477-9560